Aviceda Therapeutics has got biotech financing in 2025 off to a flying start by raising $207.5 million to take its lead drug ...
Blood centres cannot make cell therapies more accessible on their own. For decades they have partnered with hospitals to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback